Allurion Technologies (ALURD) Total Current Liabilities (2022 - 2026)
Allurion Technologies' (ALURD) quarterly Total Current Liabilities came in at $37.3 million in Q1 2026, up 134.37% YoY from $15.9 million in Q1 2025, and down 3.09% on a QoQ basis from $38.4 million in Q4 2025.
Allurion Technologies (ALURD) Total Current Liabilities (2022 - 2026) Analysis & Trends
Allurion Technologies (ALURD) has 5 years of Total Current Liabilities data on file, last reported at $37.3 million in Q1 2026.
- Quarterly Total Current Liabilities rose 134.37% year-over-year to $37.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.3 million (up 134.37% YoY) and the FY2025 annual result came in at $38.4 million, up 103.81% from the prior year.
- Total Current Liabilities slipped to $37.3 million in Q1 2026, from $38.4 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $89.9 million in Q2 2023 to a low of $11.6 million in Q2 2025.
- A 5-year average of $43.2 million and a median of $37.3 million in 2026 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Current Liabilities slumped 77.94% — and 2026, when it soared 134.37%.
- Tracing ALURD's Total Current Liabilities over 5 years: stood at $75.9 million in 2022, then dropped by 13.76% to $65.4 million in 2023, then tumbled by 71.17% to $18.9 million in 2024, then surged by 103.81% to $38.4 million in 2025, then dropped by 3.09% to $37.3 million in 2026.
- The last three Total Current Liabilities figures came in at $37.3 million (Q1 2026), $38.4 million (Q4 2025), and $11.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Allurion Technologies | 49.18 Mn | 44.13 Mn | 1.23 Mn | 37.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.26 Mn |
| Dec 31, 2025 | 38.45 Mn |
| Sep 30, 2025 | 11.62 Mn |
| Jun 30, 2025 | 11.62 Mn |
| Mar 31, 2025 | 15.90 Mn |
| Dec 31, 2024 | 18.86 Mn |
| Sep 30, 2024 | 19.24 Mn |
| Jun 30, 2024 | 23.56 Mn |
| Mar 31, 2024 | 66.22 Mn |
| Dec 31, 2023 | 65.43 Mn |
| Sep 30, 2023 | 87.23 Mn |
| Jun 30, 2023 | 89.89 Mn |
| Dec 31, 2022 | 75.87 Mn |